432 related articles for article (PubMed ID: 18063832)
1. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study.
Kelly PJ; Morrow JD; Ning M; Koroshetz W; Lo EH; Terry E; Milne GL; Hubbard J; Lee H; Stevenson E; Lederer M; Furie KL
Stroke; 2008 Jan; 39(1):100-4. PubMed ID: 18063832
[TBL] [Abstract][Full Text] [Related]
2. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
[TBL] [Abstract][Full Text] [Related]
3. MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death.
Inzitari D; Giusti B; Nencini P; Gori AM; Nesi M; Palumbo V; Piccardi B; Armillis A; Pracucci G; Bono G; Bovi P; Consoli D; Guidotti M; Nucera A; Massaro F; Micieli G; Orlandi G; Perini F; Tassi R; Tola MR; Sessa M; Toni D; Abbate R;
Stroke; 2013 Oct; 44(10):2901-3. PubMed ID: 23908067
[TBL] [Abstract][Full Text] [Related]
4. Oxidative Stress Biomarkers of Brain Damage: Hyperacute Plasma F2-Isoprostane Predicts Infarct Growth in Stroke.
Lorenzano S; Rost NS; Khan M; Li H; Lima FO; Maas MB; Green RE; Thankachan TK; Dipietro AJ; Arai K; Som AT; Pham LD; Wu O; Harris GJ; Lo EH; Blumberg JB; Milbury PE; Feske SK; Furie KL
Stroke; 2018 Mar; 49(3):630-637. PubMed ID: 29371434
[TBL] [Abstract][Full Text] [Related]
5. Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke.
Demir R; Ulvi H; Özel L; Özdemir G; Güzelcik M; Aygül R
Acta Neurol Belg; 2012 Dec; 112(4):351-6. PubMed ID: 22581515
[TBL] [Abstract][Full Text] [Related]
6. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
[TBL] [Abstract][Full Text] [Related]
8. Critical Care Needs in Patients with Diffusion-Weighted Imaging Negative MRI after tPA--Does One Size Fit All?
Faigle R; Marsh EB; Llinas RH; Urrutia VC
PLoS One; 2015; 10(10):e0141204. PubMed ID: 26517543
[TBL] [Abstract][Full Text] [Related]
9. Apparent diffusion coefficient thresholds do not predict the response to acute stroke thrombolysis.
Loh PS; Butcher KS; Parsons MW; MacGregor L; Desmond PM; Tress BM; Davis SM
Stroke; 2005 Dec; 36(12):2626-31. PubMed ID: 16269645
[TBL] [Abstract][Full Text] [Related]
10. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies.
Horstmann S; Kalb P; Koziol J; Gardner H; Wagner S
Stroke; 2003 Sep; 34(9):2165-70. PubMed ID: 12907822
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress after thrombolysis-induced reperfusion in human stroke.
Domínguez C; Delgado P; Vilches A; Martín-Gallán P; Ribó M; Santamarina E; Molina C; Corbeto N; Rodríguez-Sureda V; Rosell A; Alvarez-Sabín J; Montaner J
Stroke; 2010 Apr; 41(4):653-60. PubMed ID: 20185784
[TBL] [Abstract][Full Text] [Related]
12. Extension of the thrombolytic time window with minocycline in experimental stroke.
Murata Y; Rosell A; Scannevin RH; Rhodes KJ; Wang X; Lo EH
Stroke; 2008 Dec; 39(12):3372-7. PubMed ID: 18927459
[TBL] [Abstract][Full Text] [Related]
13. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
Montaner J; Fernández-Cadenas I; Molina CA; Monasterio J; Arenillas JF; Ribó M; Quintana M; Chacón P; Andreu AL; Alvarez-Sabín J
Stroke; 2003 Dec; 34(12):2851-5. PubMed ID: 14605329
[TBL] [Abstract][Full Text] [Related]
14. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke.
Rodríguez-Yáñez M; Sobrino T; Arias S; Vázquez-Herrero F; Brea D; Blanco M; Leira R; Castellanos M; Serena J; Vivancos J; Dávalos A; Castillo J
Stroke; 2011 Oct; 42(10):2813-8. PubMed ID: 21836082
[TBL] [Abstract][Full Text] [Related]
15. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
[TBL] [Abstract][Full Text] [Related]
16. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.
Castellanos M; Leira R; Serena J; Blanco M; Pedraza S; Castillo J; Dávalos A
Stroke; 2004 Jul; 35(7):1671-6. PubMed ID: 15166391
[TBL] [Abstract][Full Text] [Related]
17. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.
Merino-Zamorano C; Hernández-Guillamon M; Jullienne A; Le Béhot A; Bardou I; Parés M; Fernández-Cadenas I; Giralt D; Carrera C; Ribó M; Vivien D; Ali C; Rosell A; Montaner J
Stroke; 2015 Feb; 46(2):477-84. PubMed ID: 25503547
[TBL] [Abstract][Full Text] [Related]
18. Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke.
Ma L; Gao PY; Hu QM; Lin Y; Jing LN; Xue J; Chen ZJ; Wang YJ; Liu ML; Cai YF
Neurol Res; 2011 Jun; 33(5):494-502. PubMed ID: 21669118
[TBL] [Abstract][Full Text] [Related]
19. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch.
Chemmanam T; Campbell BC; Christensen S; Nagakane Y; Desmond PM; Bladin CF; Parsons MW; Levi CR; Barber PA; Donnan GA; Davis SM;
Neurology; 2010 Sep; 75(12):1040-7. PubMed ID: 20720188
[TBL] [Abstract][Full Text] [Related]
20. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
